USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SOLUBLE THERAPEUTICS, INC.
Address:
1500 1st Avenue North
BIRMINGHAM, AL 35203-
Phone:
N/A
URL:
N/A
EIN:
126372790
DUNS:
828888797
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $215,002.00 1
STTR Phase II $996,395.00 1

Award List:

Optimization of Protein Therapeutic Formulations

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$215,002.00
Agency:
HHS
Principal Investigator:
Lawrence J. Delucas – 205-934-5329
Research Institution:
University Of Alabama System
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): This proposal involves the development and validation of a novel approach to improve and accelerate the discovery of biopharmaceuticals (i.e. vaccines, monoclonal antibodies and other therapeutic proteins). Biopharmaceuticals are used to treat a variety of… More

Optimization of Protein Therapeutics Formulations

Award Year / Program / Phase:
2012 / STTR / Phase II
Award Amount:
$996,395.00
Agency:
HHS
Principal Investigator:
Lawrence J. Delucas – 205-934-5329
Research Institution:
UNIVERSITY OF ALABAMA AT BIRMINGHAM
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): This proposal involves the development of a high-throughput self-interaction chromatography (SIC) system that will be used by Soluble Therapeutics, LLC, to improve and accelerate the formulation discovery process for biopharmaceuticals (i.e. vaccines, monoclonal… More